The Effect of PAP on ISSHL Comorbided With OSA
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-70
SponsorBeijing Tsinghua Chang Gung Hospital
About this trial
This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.
Eligibility criteria
Qualifiers
aged >= 18 and <= 70,
diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI > 15/h,
diagnosed with ISSHL by AAO-HNS 2019 criteria,
ISSHL onset within 1 week.
Disqualifiers
sudden hearing loss with certain causes,
with severe comorbid diseases,
pregnant or breast-feeding women,
AHI <= 15/h,
Trial design
Treatments tested in this trial
- non-invasive positive airway pressure
- Methylprednisolone Hemisuccinate
- Ginaton
Treatment groups
102 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov